What is Celldex Therapeutics's short- term investments?

Celldex Therapeutics (CLDX) reported short- term investments of $415.73M in Q1 2026.

How has Celldex Therapeutics's short- term investments changed year-over-year?

Celldex Therapeutics's short- term investments decreased by 36.6% year-over-year, from $656.16M to $415.73M.

What is the long-term trend for Celldex Therapeutics's short- term investments?

Over 5 years (2020 to 2025), Celldex Therapeutics's short- term investments has grown at a 26.6% compound annual growth rate (CAGR), from $150.59M to $489.7M.

Celldex Therapeutics CLDX Short- term Investments

Short- term Investments at other companies

Regeneron PharmaceuticalsREGN

——

Apogee Therapeutics, Inc.APGE

——

Oruka Therapeutics, Inc.ORKA

——

Johnson & JohnsonJNJ

——

Other financials

Income statement

See full

Revenue$15.0K-97.8%

Operating income-$84.4M-34.6%

Net income-$78.7M-46.3%

EPS (diluted)-$1.18-45.7%

Balance sheet

See full

Cash & equivalents$35.7M+109%

Total debt$1.9M-44.3%

Total equity$456.2M-35.1%

Total assets$511.3M-30.9%

Cash flow

See full

Operating cash flow-$65.6M-20.6%

CapEx$1.6M+518%

Free cash flow-$67.2M-23.0%

Valuation

See full

Market cap$2.59B+75.2%

Enterprise value$2.55B+74.4%

P/S2,989.2×+2,794×

Profitability

See full

Operating margin-35,688.5%-39,114pp

Net margin-32,753.6%-35,519pp

FCF margin-26,125.8%-28,907pp

Returns & leverage

See full

Return on equity-48.9%-498pp

Debt / equity0×0.0×

Current ratio8.9×-12.7×

Where this comes from

Reported directly by Celldex Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.

The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celldex Therapeutics's short- term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Celldex Therapeutics's short- term investments?: Celldex Therapeutics (CLDX) reported short- term investments of $415.73M in Q1 2026.
How has Celldex Therapeutics's short- term investments changed year-over-year?: Celldex Therapeutics's short- term investments decreased by 36.6% year-over-year, from $656.16M to $415.73M.
What is the long-term trend for Celldex Therapeutics's short- term investments?: Over 5 years (2020 to 2025), Celldex Therapeutics's short- term investments has grown at a 26.6% compound annual growth rate (CAGR), from $150.59M to $489.7M.